Found 14 matching trials
MEG Study of Acute STX209 Effects in ASD
EARLY_PHASE1This is a single-site, randomized, acute dose-response study to determine w...
Location
Children's Hospital of Phladelphia
An Open Label Extension Study of STX209 in Subjects With Fragile X Syndrome
PHASE2Study 22001, "A Double-Blind, Placebo-Controlled, Flexible-Dose Evaluation ...
Location
University of California-Los Angeles Neuropsychiatric Institute
Efficacy and Safety Study of STX209 (Arbaclofen) for Social Withdrawal in Adolescents and Adults With Fragile X Syndrome
PHASE3To explore the efficacy, safety and tolerability of STX209 (arbaclofen) adm...
Location
Southwest Autism Research & Resource Center
An Open Label Extension Study in Subjects With Fragile X Syndrome
PHASE3This study will enroll subjects who have completed Protocols 209FX301, 209F...
Location
Seaside Therapeutics Site #16
Modulation of the Brain Excitatory/Inhibitory (E/I) Balance in Autism Spectrum Disorder (ASD)
NAThis study investigates the brain response to a single acute dose of Arbacl...
Location
King's College London
Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders
PHASE3This is an open-label extension protocol that will provide necessary data o...
Location
Southwest Autism Research & Resource Center
Arbaclofen in Children and Adolescents With ASD
PHASE2AIMS-2-CT-01 is a randomized, double-blind, placebo controlled, study to ex...
Location
Robert Debré Hospital
Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome
PHASE3There will be four study periods: Screening (up to 14 days in length), the ...
Location
Southwest Autism Research & Resource Center
Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome
PHASE2The study objective is to explore the efficacy, safety and tolerability of ...
Location
Southwest Autism Research & Resource Center
Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001
N/AThe subjects that meet the inclusion and exclusion criteria and consent to ...
Location
Southwest Autism Research & Resource Center